Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of striatal motoric subregions in familial frontotemporal dementia with parkinsonism harboring the C9orf72 repeat expansions. | NPJ Parkinsons Dis | 2022 | 36202819 | PubTator, text mining | PubMed |
| Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington's Disease Presenting as Young Age-Onset Parkinsonism. | J Mov Disord | 2022 | 36202210 | PubTator, text mining | PubMed |
| Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington's disease. | Regen Ther | 2022 | 36196447 | PubTator, text mining | PubMed |
| Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 36193151 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
| DNA methylation as a potential mediator of the association between prenatal tobacco and alcohol exposure and child neurodevelopment in a South African birth cohort. | Transl Psychiatry | 2022 | 36180424 | PubTator, text mining | PubMed |
| Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks. | Proc Natl Acad Sci U S A | 2022 | 36161926 | PubTator, text mining | PubMed |
| A mechanistic overview of approaches for the treatment of psychostimulant dependence. | Front Pharmacol | 2022 | 36160447 | PubTator, text mining | PubMed |
| New Biology of Pheochromocytoma and Paraganglioma. | Endocr Pract | 2022 | 36150627 | PubTator, text mining | PubMed |
| Generation of a TPH2-EGFP reporter cell line for purification and monitoring of human serotonin neurons in vitro and in vivo. | Stem Cell Reports | 2022 | 36150384 | PubTator, text mining | PubMed |
| Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. | Stem Cell Reports | 2022 | 36150382 | PubTator, text mining | PubMed |
| How "Neuronal" Are Human Skin Mast Cells? | Int J Mol Sci | 2022 | 36142795 | PubTator, text mining | PubMed |
| Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson's Disease. | Int J Mol Sci | 2022 | 36142718 | PubTator, text mining | PubMed |
| Neuro-Inflammaging and Psychopathological Distress. | Biomedicines | 2022 | 36140234 | PubTator, text mining | PubMed |
| Imaging the Limbic System in Parkinson's Disease-A Review of Limbic Pathology and Clinical Symptoms. | Brain Sci | 2022 | 36138984 | PubTator, text mining | PubMed |
| Molecular Imaging in Parkinsonian Disorders-What's New and Hot? | Brain Sci | 2022 | 36138882 | PubTator, text mining | PubMed |
| White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels. | Neuroimage Clin | 2022 | 36126513 | PubTator, text mining | PubMed |
| Stereoselective Synthesis of Benzo[a]quinolizidines via Aerobic DDQ-Catalyzed Allylation and Reductive Cyclization. | ACS Omega | 2022 | 36120044 | PubTator, text mining | PubMed |
| The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review. | Front Neurosci | 2022 | 36117625 | PubTator, text mining | PubMed |
| Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT). | Psychiatry Clin Neurosci | 2022 | 36114799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=27